Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ramius
Ramius
The Law Office of Abe Shainberg Launches an Investigation into the Possible Breaches of Fiduciary Duty by the Board of Cypress Bioscience, Inc. in Connection with the Sale of Company to Ramius V & O Acquisition, LLC– CYPB
Yahoo/BusinessWire
Sat, 12/18/10 - 12:20 pm
Cypress Bioscience
Ramius
legal
lawsuits
Cypress jumps on buyout deal
Marketwatch
Wed, 12/15/10 - 10:35 am
M&A
Cypress Bioscience
Ramius
Cypress Surges After Ramius Boosts Buyout Offer 29 Percent to $212 Million
Bloomberg
Fri, 12/10/10 - 12:07 pm
Cypress Bioscience
Ramius
M&A
Cypress Would Rather Sell to Anyone Besides Ramius
HedgeFund.net
Mon, 10/4/10 - 11:54 am
Ramius
Cypress Bioscience
Cypress Bioscience board rejects new Ramius bid
Yahoo/AP
Tue, 09/28/10 - 11:21 am
Ramius
Cypress Bioscience
M&A
Cypress Bioscience Board of Directors Unanimously Rejects Ramius' Unsolicited Tender Offer Board Authorizes Broad Evaluation of Strategic Alternatives to Maximize Stockholder Value; Board Recommends Cypress Stockholders NOT Tender Shares Into Ramius Offer
Tue, 09/28/10 - 10:50 am
Cypress Bioscience
Ramius
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer
Motley Fool
Thu, 09/16/10 - 12:24 pm
Cypress Bioscience
Ramius
M&A
Cypress Bioscience Sends Letter to Ramius
Yahoo
Tue, 08/17/10 - 12:02 pm
Ramius
Cypress Bioscience
M&A
Cypress rebuffs Ramius buyout offer
Fierce Biotech
Fri, 08/6/10 - 11:24 am
Cypress Bioscience
Ramius
M&A
Cypress Biosciences up 22% in pre-market trading
Marketwatch
Tue, 08/3/10 - 11:15 am
Cypress Bioscience
Ramius
M&A
Cypress Bioscience confirms Ramius' buyout offer
Yahoo/AP
Tue, 07/20/10 - 03:34 pm
M&A
Cypress Bioscience
Ramius
Ramius unit bids $4-share for Cypress Bioscience
Marketwatch
Mon, 07/19/10 - 09:50 am
Ramius
Cypress Bioscience
M&A